Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Current Deferred Revenue (2016 - 2025)

Bio-Techne has reported Current Deferred Revenue over the past 12 years, most recently at $33.0 million for Q4 2025.

  • Quarterly results put Current Deferred Revenue at $33.0 million for Q4 2025, up 8.55% from a year ago — trailing twelve months through Dec 2025 was $33.0 million (up 8.55% YoY), and the annual figure for FY2025 was $35.3 million, up 26.39%.
  • Current Deferred Revenue for Q4 2025 was $33.0 million at Bio-Techne, up from $32.7 million in the prior quarter.
  • Over the last five years, Current Deferred Revenue for TECH hit a ceiling of $35.6 million in Q1 2025 and a floor of $18.7 million in Q1 2021.
  • Median Current Deferred Revenue over the past 5 years was $26.2 million (2023), compared with a mean of $26.8 million.
  • Biggest five-year swings in Current Deferred Revenue: skyrocketed 45.57% in 2021 and later decreased 3.53% in 2023.
  • Bio-Techne's Current Deferred Revenue stood at $19.1 million in 2021, then grew by 23.16% to $23.5 million in 2022, then rose by 28.09% to $30.1 million in 2023, then rose by 1.0% to $30.4 million in 2024, then grew by 8.55% to $33.0 million in 2025.
  • The last three reported values for Current Deferred Revenue were $33.0 million (Q4 2025), $32.7 million (Q3 2025), and $35.3 million (Q2 2025) per Business Quant data.